Secondary Prevention After Coronary Artery Bypass Graft Surgery | Zendy

Judson B. Williams | Zendy; Elizabeth R. DeLong | Zendy; Eric D. Peterson | Zendy; Rachel S. Dokholyan | Zendy; FangShu Ou | Zendy; T. Bruce Ferguson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Secondary Prevention After Coronary Artery Bypass Graft Surgery

Author(s) -

Judson B. Williams,

Elizabeth R. DeLong,

Eric D. Peterson,

Rachel S. Dokholyan,

FangShu Ou,

T. Bruce Ferguson

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.981068

Subject(s) - medicine , context (archaeology) , medical prescription , aspirin , randomized controlled trial , hazard ratio , emergency medicine , psychological intervention , specialty , physical therapy , intensive care medicine , surgery , family medicine , nursing , paleontology , confidence interval , biology

Despite evidence supporting the use of aspirin, β-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering therapies in eligible patients, adoption of these secondary prevention measures after coronary artery bypass grafting has been inconsistent. We sought to rigorously test on a national scale whether low-intensity continuous quality improvement interventions can be used to speed secondary prevention adherence after coronary artery bypass grafting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research